Cargando…
Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
Autores principales: | Aleong, Ryan G., Sauer, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586484/ https://www.ncbi.nlm.nih.gov/pubmed/28862958 http://dx.doi.org/10.1161/JAHA.117.007087 |
Ejemplares similares
-
Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks
por: Fleeman, Blake E., et al.
Publicado: (2019) -
Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017) -
Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006) -
Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
por: Tsuji, Yukiomi, et al.
Publicado: (2021) -
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)